Company | Ticker | Business Description | Underwriters | Offer Date |
---|---|---|---|---|
Bioventus> | BVS> | Offers orthobiologics products for musculoskeletal conditions. | Morgan Stanley JP Morgan |
02/10/21 |
BioVie> | BIVI> | Phase 2 biotech developing therapies for cirrhosis. | ThinkEquity EF Hutton |
09/17/20 |
News Results for BIOV |
---|